Diisopropylethylamine → (1R,2R)-N,1-dihydroxy-2-[({4-[(2-methylquinolin-4-yl)methoxy]phenyl}sulfonyl)amino]cyclopentanecarboxamide
Reaction equation
[OH:1][C@:2]1([C:30]([OH:32])=O)[CH2:6][CH2:5][CH2:4][C@H:3]1[NH:7][S:8]([C:11]1[CH:16]=[CH:15][C:14]([O:17][CH2:18][C:19]2[C:28]3[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=3)[N:22]=[C:21]([CH3:29])[CH:20]=2)=[CH:13][CH:12]=1)(=[O:10])=[O:9].Cl.NO.F[P-](F)(F)(F)(F)F.[N:43]1([O:52][P+](N(C)C)(N(C)C)N(C)C)C2C=CC=CC=2N=N1.C(N(C(C)C)CC)(C)C>CN(C=O)C.CC#N.O>[OH:52][NH:43][C:30]([C@@:2]1([OH:1])[CH2:6][CH2:5][CH2:4][C@H:3]1[NH:7][S:8]([C:11]1[CH:16]=[CH:15][C:14]([O:17][CH2:18][C:19]2[C:28]3[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=3)[N:22]=[C:21]([CH3:29])[CH:20]=2)=[CH:13][CH:12]=1)(=[O:9])=[O:10])=[O:32]Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of (1R,2R)-1-hydroxy-2-[({4-[(2-methylquinolin-4-yl)methoxy]phenyl}sulfonyl)amino]cyclopentanecarboxylic acid (0.08 g) in DMF (0.8 mL) was added hydroxylamine hydrochloride (2 eq), benzotriazol-1-yloxytris(dimethylamino)-phosphonium hexafluorophosphate (1.3 eq) and diisopropylethylamine (4 eq). The reaction was stirred overnight and injected directly onto a reverse phase HPLC (CH3CN/H2O) to afford (1R,2R)-N,1-dihydroxy-2-[({4-[(2-methylquinolin-4-yl)methoxy]phenyl}sulfonyl)amino]cyclopentanecarboxamide (0.03 g, 37%) as a white solid. MS: 472.1 (M+H)+
Sources & evidence
- ORD record
- ord-2a66f603c8944f23ac6cecc8e850ba20
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07595327B2
Reaction notes
Loading…